# Consumption of Oral Artificial Sweeteners on Platelet Aggregation and Polyol Excretion

> **NCT04731363** · NA · ACTIVE_NOT_RECRUITING · sponsor: **The Cleveland Clinic** · enrollment: 50 (actual)

## Conditions studied

- Cardiovascular Risk Factor

## Interventions

- **DIETARY_SUPPLEMENT:** xylitol, 30g
- **DIETARY_SUPPLEMENT:** erythritol, 30g
- **DIETARY_SUPPLEMENT:** xylitol, 5g
- **DIETARY_SUPPLEMENT:** glucose, 30g

## Key facts

- **NCT ID:** NCT04731363
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-03-10
- **Primary completion:** 2023-08-30
- **Final completion:** 2026-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04731363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04731363, "Consumption of Oral Artificial Sweeteners on Platelet Aggregation and Polyol Excretion". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04731363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*